Clarithromycin laurate salt: physicochemical properties and pharmacokinetics after oral administration in humans

Bashar A. Alkhalidi,Hatim S. AlKhatib,Mohammad Saleh,Saja Hamed,Yasser Bustanji,Nader Al Bujuq,Naji Najib,Susana Torrado-Susana,Al-Sayed Sallam
DOI: https://doi.org/10.1080/10837450.2018.1547749
2018-12-07
Pharmaceutical Development and Technology
Abstract:OBJECTIVE: To prepare and characterize the physicochemical and pharmacokinetic properties of clarithromycin laurate (CLM-L), a fatty acid salt of clarithromycin (CLM).METHODS: CLM-L was prepared by a simple co-melting process. The formation of CLM-L was confirmed using FTIR, <sup>1</sup>H NMR, and <sup>13</sup>C NMR. Solubility, intrinsic dissolution rate (IDR), and partitioning properties of CLM-L were determined and compared to those of CLM. Bioavailability of CLM from CLM-L tablets was evaluated in healthy volunteers and compared to immediate release CLM tablets.RESULTS: CLM-L showed lower aqueous solubility, higher partitioning coefficient, and slower dissolution rate. Tablets of CLM-L also showed a significantly slower in vitro release in comparison to CLM tablets. C<sub>max</sub>, T<sub>max</sub> and AUC<sub>0→∞</sub> of CLM-L tablets and immediate release CLM tablets did not show a significant difference. However, the AUC<sub>0→∞</sub> for the CLM-L tablets tended to be higher than that of CLM tablets at all-time points.CONCLUSION: CLM-L was successfully prepared and its formation was confirmed. CLM-L was more hydrophobic than CLM. It exhibited a slight in vivo absorption enhancement in comparison to CLM. However, its pharmacokinetic behavior was comparable to that of CLM.
pharmacology & pharmacy
What problem does this paper attempt to address?